PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Module 1 15 minutes: Radionuclide Targeted Treatment in Progressing Metastatic Prostate Cancer – Presented by Michael Hofman, MBBS (Hons), FRACP, FAANMS, FICIS 20 minutes: Discussion Moderators Phillip J. Koo, MD, Alicia Morgans, MD, MPH, and Neal Shore, MD, FACS Biographies: Professor Michael Hofman, MBBS (Hons), FRACP, FAANMS,…
Zachary Klaassen speaks with Matthew Cooperberg about the integration of OnQ™ Prostate assisted Focal One® Robotic HIFU for prostate cancer treatment. Dr. Cooperberg discusses how…
Ashish Kamat speaks with Marco Moschini about expanding active surveillance criteria for recurrent low-grade bladder cancer. Dr. Moschini presents his single-center retrospective study from San…
At the 2025 UCSF-UCLA PSMA Conference, Tanya Dorff addresses treatment sequencing in advanced prostate cancer. She notes PARP inhibitors show superior efficacy when used early…
Ashish Kamat speaks with Nimira Alimohamed about the evolution of circulating tumor DNA (ctDNA) in muscle invasive bladder cancer management. Dr. Alimohamed explains that current…
Zachary Klaassen speaks with Oliver Sartor about treatment intensification in metastatic hormone-sensitive prostate cancer, focusing on triplet therapy selection. Dr. Sartor traces the evolution from…
Ashish Kamat speaks with Shilpa Gupta about the JAVELIN trial and its impact on bladder cancer treatment. Dr. Gupta discusses how this study established avelumab…
At the 2025 UCSF-UCLA PSMA Conference, Denise Merlino addresses theranostics and dosimetry reimbursement for US clinicians. She emphasizes successful payment requires educating payers, using appropriate…
At the 2025 UCSF-UCLA PSMA Conference, Dr. Tagawa discusses PSMA-targeting antibodies versus small molecule approaches for prostate cancer therapy. He highlights antibodies’ distinct pharmacokinetics, circulating…
Pedro Barata interviews Scott Tagawa about radioligand therapy research, focusing on actinium-225 PSMA antibody constructs. Dr. Tagawa explains that antibodies like rosopatamab offer advantages over…
Matthew Cooperberg moderates a patient-oriented discussion with Jonathan Tward and Ashley Ross about a prostate cancer test that uses artificial intelligence to analyze digital pathology…
